Multiple episodes of paediatric <i>Clostridioides difficile</i> infection (pCDI) in the context of autoimmune polyendocrine syndrome type 1

We describe the case of a young child who experienced multiple episodes of <i>Clostridioides difficile</i> infection (CDI) with pronounced meteorism and watery diarrhoea. One episode progressed to severe disease requiring admission to intensive care. Initial CDI episodes were managed with metronidazole and vancomycin. For the recurrent CDI, fidaxomicin-a narrow-spectrum antibiotic with targeted activity against <i>C. difficile</i>-was administered, resulting in sustained clinical remission of CDI-related symptoms. During subsequent follow-up, the patient was diagnosed with autoimmune polyendocrine syndrome type 1 (APS-1), a rare monogenic disorder characterised by immune dysregulation and increased susceptibility to infection. The underlying immunocompromised state likely contributed to the multiple CDI episodes. To our knowledge, this is the first reported case of paediatric CDI associated with APS-1.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2025-10-01
DOI
https://doi.org/10.1136/bcr-2024-263544
Primary Topic
Adrenal Hormones and Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multiple episodes of paediatric Clostridioides difficile infection (pCDI) in the context of autoimmune polyendocrine syndrome type 1

Nadja Klafke, Harald Michael Kirr, Anja Lütke
BMJ Case Reports
Adrenal Hormones and Disorders
article

Multiple episodes of paediatric Clostridioides difficile infection (pCDI) in the context of autoimmune polyendocrine syndrome type 1

Nadja Klafke, Harald Michael Kirr, Anja Lütke
article en

Abstract

We describe the case of a young child who experienced multiple episodes of <i>Clostridioides difficile</i> infection (CDI) with pronounced meteorism and watery diarrhoea. One episode progressed to severe disease requiring admission to intensive care. Initial CDI episodes were managed with metronidazole and vancomycin. For the recurrent CDI, fidaxomicin-a narrow-spectrum antibiotic with targeted activity against <i>C. difficile</i>-was administered, resulting in sustained clinical remission of CDI-related symptoms. During subsequent follow-up, the patient was diagnosed with autoimmune polyendocrine syndrome type 1 (APS-1), a rare monogenic disorder characterised by immune dysregulation and increased susceptibility to infection. The underlying immunocompromised state likely contributed to the multiple CDI episodes. To our knowledge, this is the first reported case of paediatric CDI associated with APS-1.

BMJ Case ReportsVol. 18(10)
RAG Aktiengesellschaft (Germany) (DE), Tillotts Pharma (Switzerland) (CH), Kernkraftwerk Gundremmingen (DE)
Tillotts Pharma
Openalex Percentile: Top 58%
Adrenal Hormones and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Multiple episodes of paediatric <i>Clostridioides difficile</i> infection (pCDI) in the context of autoimmune polyendocrine syndrome type 1 — Nadja Klafke, Harald Michael Kirr, et al. · BMJ Case Reports (2025) | TGRS Research Map | TGRS